The acute effect of an echo-contrast agent on right ventricular dimensions and contractility in pigs

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 1, 2008, Pages 86-91

  Bramos, Dimitris ^a,c   Tsirikos, Nikolaos ^a   Kottis, Giorgos ^b   Pamboucas, Constantinos ^a   Kostopoulou, Vichy ^a   Trika, Crysanthi ^a   Ikonomidis, Ignatios ^a   Toumanidis, Savvas ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

Echocardiography; Right ventricle; Ultrasound contrast agent

Indexed keywords

SONOVUE;

ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; LOW DRUG DOSE; LUNG PRESSURE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD PRESSURE; CONTRAST MEDIA; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; HEART VENTRICLES; INJECTIONS, INTRAVENOUS; MYOCARDIAL CONTRACTION; PHOSPHOLIPIDS; PULMONARY ARTERY; RANDOM ALLOCATION; SULFUR HEXAFLUORIDE; SWINE; SYSTOLE; VENTRICULAR FUNCTION, RIGHT;

EID: 38349114216     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31815c660c     Document Type: Article

References (32)

1. Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysenergic myocardium early after acute myocardial infarction. J Am Coll Cardiol. 2001;38:19.
2. Main ML, Magalski A, Morris BA, et al. Combined assessment of microvascular integrity and contractile reserve improves differentiation of stunning and necrosis after acute anterior wall myocardial infarction. J Am Coll Cardiol. 2002;40:1079-1084.
3. Wei K, Jayaweera AR, Firoozan S, et al. Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol. 1998;32:252-260.
4. Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol. 2005;45:329-335.
5. Torzilli G. Adverse effects associated with SonoVue use. Expert Opin Drug Saf. 2005;4:399-401.
6. Schneider M. Characteristics of SonoVue trade mark. Echocardiography. 1999;16:743-746.
7. Wiggins JR, Jacob G, Goldstein HA. Safety of levovist injection in patients undergoing exercise stress echocardiography: a placebo-controlled study. Acad Radiol. 1998;5(Suppl 1):S192-S194.
8. Bokor D. Diagnostic efficacy of SonoVue. Am J Cardiol. 2000;86:19G-24G.
9. Geny B, Mettauer B, Muan B et al. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol. 1993;22:1193-1198.
10. Bokor D, Chambers JB, Rees PJ et al. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol. 2001;36:104-109.
11. Morel DR, Schwieger I, Hohn L et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol. 2000;35:80-85.
12. Scientific discussion, European Medicines Agency 2004, CPMP/0053/01.
13. Soman P, Lahiri A, Senior R. Safety of an intravenous second generation contrast agent in patients with severe left ventricular dysfunction. Heart. 2000;84:634-635.
14. Schwarz KQ, Bezante GP, Chen X et al. Hemodynamic effects of microbubble echo contrast. J Am Soc Echocardiogr. 1996;9:795-804.
15. Schneider M, Arditi M, Barrau MB et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol. 1995;30:451-457.
16. Tei C, Pilgrim JP, Shah PM et al. The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation. Circulation. 1982;66:665-671.
17. Reynertson SI, Kundur R, Mullen RG, et al. Asymmetry of right ventricular enlargement in response to tricuspid regurgitation. Circulation 1999;100:465-467.
18. Sherman HL, Avelar E, Grossman PM, et al. Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure. Am Heart J. 2000;139:782-787.
19. Ostensen J, Hede R, Myreng Y, et al. Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs, but not in monkeys or rabbits. Acta Physiol Scand. 1992;144:307-315.
20. Schwarz KQ, Bezante GP, Becher H, et al. Efficacy SH U 508 A (Levovist) as blood pool enhancer in the Doppler evaluation of multiple vascular regions. Radiol Med. 1994;87:3-14.
21. Runge VM. A Review of Contrast Media Research in 1999-2000. Invest Radiol. 2001;36:123-130.
22. Weissman NJ, Cohen MC, Hack TC, et al. Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial. Am Heart J. 2000;139:399-404.
23. Skyba DM, Kaul S. Advances in microbubble technology. Coron Artery Dis. 2000;11:211-219.
24. Nanda A, Wistran D, Karlsberg R, et al. Multicenter evaluation of SonoVue for improved endocardial border delineation. Echocardiography. 2002;19:27-36.
25. de Groot MC, van Zwieten-Boot BJ, van Grootheest AC. Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent. Ned Tijdschr Geneeskd. 2004;148:1887-1888.
26. Dijkmans PA, Visser CA, Kamp O. Adverse reactions to ultrasound contrast agents: Is the risk worth the benefit? Eur J Echocardiogr. 2005;6:363-366.
27. Timperley J, Mitchell AR, Thibault H, et al. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr. 2005;18:163-167.
28. Tsutsui JM, Elhendy A, Xie F, et al. Safety of dobutamine stress real time myocardial contrast echocardiography. J Am Coll Cardiol. 2005;45:1235-1242.
29. Skyba DM, Camarano G, Goodman NC, et al. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second generation contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol. 1996;28:1292-1300
30. Wauthy P, Pagnamenta A, Vassalli F, et al. Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol. 2004;286:H1441-H1447.
31. Dehring DJ, Wismar BL. Intravascular macrophages in pulmonary capillaries of humans. Am Rev Respir Dis. 1989;139:1027-1029.
32. Tucker A, McMurtry IF, Reeves JT, et al. Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude. Am J Physiol. 1975;228:762-767.